Author:
Tiruneh Tegenaw,Enawgaw Bamlaku,Shiferaw Elias
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.
2. Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, et al. Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leuk Lymphoma. 2010;51(6):995–1006.
3. Yee-Loong Tang D, Wai-Kit Chia M, Yap W, Shuib Salwati D. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report. Malays J Pathol. 2016;38(3):315.
4. Larson RA. Etiology and management of therapy-related myeloid leukemia. ASH Educ Program Book. 2007;2007(1):453–9.
5. Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA. Therapy-related myeloid neoplasms. Am J Clin Pathol. 2015;144(2):207–18.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献